Ledger.Open graph →
SEC Form D · Amendment · filed June 5, 2014

SymbioCellTech, LLC

Offering
$7.0M
Sold
$2.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SALT LAKE CITY, UT
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Jill Maguire-Ward · New York, NYExec · DirectorAlan O'Brien · Irvine, CADirectorR. M. Daley · Seattle, WAExec · Director · PromoterPerry N. Dellelce · Herndon, VADirector · PromoterMark G. Burton · San Francisco, CAExecGeorge Reiss · Salt Lake City, UTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗